| CAS NO: | 4991-65-5 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 1g | 电议 |
| 2g | 电议 |
| 5g | 电议 |
| 10g | 电议 |
| 25g | 电议 |
| 50g | 电议 |
| Molecular Weight (MW) | 168.17 |
|---|---|
| Formula | C7H4O3S |
| CAS No. | 4991-65-5 |
| Storage | -20℃ for 3 years in powder form |
| -80℃ for 2 years in solvent | |
| Solubility (In vitro) | DMSO: 34 mg/mL (202.2 mM) |
| Water: < 1 mg/mL | |
| Ethanol: 34 mg/mL (202.17 mM) | |
| SMILES | O=C1OC2=CC(O)=CC=C2S1 |
| Synonyms | Tioxolone; Thioxolone; |
| In Vitro | In vitro activity: Tioxolone is reported to possess cytostatic, antipsoriatic, antibacterial and anti-mycotic properties. Tioxolone is also added to some cosmetics (e.g. hair shampoos and skin cleansers), due to claims for its oil-regulating and antibacterial properties. The three-dimensional framework of Tioxolone is further stabilized by π-π interactions between the oxathiolone and benzene rings in partially overlapping molecules. |
|---|---|
| In Vivo | Tioxolone, a Benzoxathiol derivatives, has been used in the local therapy of psoriasis vulgaris and acne, and also reported to have anti-bacterial, anti-mycotic, and cytostatic properties. |
| Animal model | |
| Formulation & Dosage | |
| References | Acta Crystallogr C. 2004 Jun;60(Pt 6):o395-6; Exp Mol Med. 2011 May 31;43(5):313-21. |
m.cnreagent.com